Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial | Zendy

ChangHung Kuo | Zendy; PingI Hsu | Zendy; FuChen Kuo | Zendy; Sophie Sheng-Wen Wang | Zendy; HongMing Hu | Zendy; Chinsu Liu | Zendy; SengKee Chuah | Zendy; YenHsu Chen | Zendy; MengChiao Hsieh | Zendy; Dang Wu | Zendy; HuiHwa Tseng | Zendy

Open Access

Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial

Author(s) -

ChangHung Kuo,

PingI Hsu,

FuChen Kuo,

Sophie Sheng-Wen Wang,

HongMing Hu,

Chinsu Liu,

SengKee Chuah,

YenHsu Chen,

MengChiao Hsieh,

Dang Wu,

HuiHwa Tseng

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks361

Subject(s) - levofloxacin , metronidazole , helicobacter pylori , medicine , randomized controlled trial , antibacterial agent , helicobacter infections , gastroenterology , antibiotics , microbiology and biotechnology , biology

This prospective study was designed to compare the efficacies of levofloxacin-containing and high-dose metronidazole-containing quadruple therapies after failure of standard triple therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research